The benchmark equity indices snapped their two-session winning streak on Monday. The NSE Nifty 50 ended 19.65 points or 0.08% ...

If approved, CUTX-101 will be the first and only FDA-approved treatment available for Menkes disease, a rare X-linked ...

RAD 101 is Radiopharm’s novel small-molecule imaging agent targeting fatty acid synthase (FASN) and radiolabelled with Fluorine-18 for the diagnosis of suspected recurrent brain metastases from solid ...

Latest India Stock/Share Market News, NSE, BSE, Global Market, Sensex Nifty. Live Business News headlines on IPO, Stock/Share tips, Personal Finance, Budget, Tax, Mutual Fund, Commodity Market more ...

The former speaker failed to appreciate the groundswell of support for banning the practice, refusing to give an inch amid ...

Dec 15 (Reuters) - Australia’s Fortescue said on Monday it will buy the remaining 64% of Alta Copper in a deal implying a total equity value of C$139 million ($101 million) for the Toronto-listed ...

While the Federal Reserve cut interest rates in the US a couple of days back, in Australia, the trend appears to be moving in ...

Gen Z and millennial traders looking to take on riskier bets in the market told us why they can't stop opening up prop ...

BridgeBio Oncology Therapeutics (BBOT) targets KRAS and PI3Ka malignancies with next-generation small molecule therapeutics, ...

The Rs 922-crore IPO had attracted strong investor demand, getting subscribed nearly 102 times during the bidding window from ...

Dyne Therapeutics, Inc.’s 2026 outlook with key DYNE-101/251 data, FDA submission plans, and extended cash runway. Click for ...

Shares of Aequs jumped over 12% to touch an intraday high of INR 157 on the BSE following their listing today. The stock ...